The global market for tocopheryl nicotinate is expected to grow at a significant CAGR during the forecast period (2021-2027). Tocopheryl nicotinate is a tocopherol-nicotinic acid ester. The esterified version of vitamin E (tocopherol) is sold commercially (alpha-tocopheryl acetate, alpha-tocopheryl succinate and alpha-tocopheryl nicotinate). Antioxidant and vasodilatory effects of alpha-tocopheryl nicotinate. It can be used as a gentle warming agent without the redness that nicotinic acid is known for. Tocopherol is authorised in Japan under the trade name Juvela N for the treatment of symptoms associated with hypertension, hyperlipidemia, and peripheral circulatory disruption caused by arteriosclerosis obliterans. Platelet aggregation is inhibited by tocopherol.
Free Sample Copy @ https://www.omrglobal.com/request-sample/tocopheryl-nicotinate-market
Natural components, such as vitamins and minerals, are included in an expanding number of skincare products now in the market to preserve healthy and beautiful skin. As a result, there is a huge need for tocopheryl nicotinate in cosmetics. This comprises skincare products that include tocopheryl nicotinate and provides UVA and UVB protection, such as sun protection SPF formulations. Thus, the increasing demand for tocopheryl nicotinate as skin conditioning agents is expected to drive market growth during the forecast period.
A Full Report of Global Tocopheryl Nicotinate Market is Available at:
https://www.omrglobal.com/industry-reports/tocopheryl-nicotinate-market
According to WHO, cardiovascular diseases (CVDs) remain the leading cause of mortality globally. CVDs claimed the lives of 17.9 million individuals globally in 2019, accounting for 32% of all fatalities. Heart attacks and strokes were responsible for 85% of these fatalities. Low- and middle-income nations account for about three-quarters of CVD fatalities. CVDs were responsible for 38% of the 17 million premature deaths (before the age of 70) caused by noncommunicable illnesses in 2019. Tocopheryl nicotinate is used as an anti-cholesterol to reduce the risks of cardiovascular disorders. Therefore the rising prevalence of CVDs is expected to drive the growth of the global tocopheryl nicotinate market.
Global Tocopheryl Nicotinate Market – Segmentation
By Product Type
Above 97 % Purity
97 % Purity
By Application
Vascular Disorders
Abnormal Lipid Metabolism
Antioxidants
Skin Conditioning Agents
Cosmetics
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Tocopheryl Nicotinate Market – Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Beijing Brilliance Bio
Cosmol Co. Ltd.
TRI-K Industries
Beijing Brilliance Biochemical Co. Ltd.
Hangzhou Dayangchem Co. Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/tocopheryl-nicotinate-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
(This release has been published on Global Market Post.
Global Market Post is not responsible for any content included in this release.)
